Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1057071

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1057071

Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

PUBLISHED:
PAGES: 353 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 48+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest growing market for hematology drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The hematology drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider hematology drugs market; and compares it with other markets.

The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by distribution channel, segmentation by route of administration, segmentation by drug classification, segmentation by mode of purchase.
  • Market Characteristics - The market characteristics section of the report defines and explains the hematology drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the hematology drugs industry supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products in the hematology drugs market along with key features and differentiators for those products.
  • Customer Information - This chapter covers recent customers' trends/preferences in the global hematology drugs market.
  • Trends And Strategies - This chapter describes the major trends shaping the global hematology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact - This chapter describes the COVID impact on the global hematology drugs industry.
  • Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Global Macro Comparison - The global hematology drugs market comparison with macro-economic factors gives the hematology drugs market size, percentage of GDP, and average hematology drugs market expenditure.
  • Regional Market Size and Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global hematology drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the pharmaceutical drugs market of which the hematology drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2015-20 and 2020-25 values, and regional and country analyses for the pharmaceutical drugs market.
  • Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for hematology drugs companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Type: Hemophilia; Blood Products; Anemia; Other Blood Disorder Drugs
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
  • 3) By Route Of Administration: Oral; Parenteral; Others
  • 4) By Drug Classification: Branded Drugs; Generic Drugs
  • 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
  • Companies Mentioned: Takeda Pharmaceutical Company; Roche Holding AG; Amgen Inc.; Novartis AG; Novo Nordisk A/S
  • Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hematology drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: o&s366

Table of Contents

1. Hematology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Type
  • 6.3. Segmentation By Distribution Channel
  • 6.4. Segmentation By Route Of Administration
  • 6.5. Segmentation By Drug Classification
  • 6.6. Segmentation By Mode Of Purchase

7. Hematology Drugs Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Type
    • 7.2.1. Hemophilia
    • 7.2.2. Blood Products
    • 7.2.3. Anemia
    • 7.2.4. Other Blood Disorder Drugs
  • 7.3. Segmentation By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies/ Drug Stores
    • 7.3.3. Others
  • 7.4. Segmentation By Route Of Administration
    • 7.4.1. Oral
    • 7.4.2. Parenteral
  • 7.5. Segmentation By Drug Classification
    • 7.5.1. Branded Drugs
    • 7.5.2. Generic Drugs
  • 7.6. Segmentation By Mode Of Purchase
    • 7.6.1. Over The Counter Drugs
    • 7.6.2. Prescription-Based Drugs

8. Hematology Drugs Market, Product/Service Analysis - Product/Service Examples

9. Hematology Drugs Market, Supply Chain Analysis

  • 9.1. Supply Chain
    • 9.1.1. Raw Material Suppliers
    • 9.1.2. Contract Research Organization (CRO)
    • 9.1.3. Hematology Drugs Manufacturer
    • 9.1.4. Contract Manufacturing Organization (CMO)
  • 9.2. Distribution
    • 9.2.1. Wholesalers/Distributors
    • 9.2.2. Retailers (Pharmacies) And Hospitals
    • 9.2.3. Hematologists
  • 9.3. End-Users

10. Hematology Drugs Market Customer Information

  • 10.1. Hemophilia Patients Challenges And Concerns in Europe
  • 10.2. Rise in Anemia in Children and Women in India
  • 10.3. Sickel Cell Disease Impact On Economy

11. Hematology Drugs Market Trends And Strategies

  • 11.1. Use of Biomarkers for Drug Development
  • 11.2. Sickle Cell Disease Pain Management In Infusion Centers
    • 11.3. 3D Printing Technology
  • 11.4. Artificial Intelligence (AI) In Hematology
  • 11.5. Telemedicine Support in Rare Disease

12. Impact Of COVID-19 On The Hematology Drugs Market

  • 12.1. Clinical Trial Delays
  • 12.2. Supply Chain Issues
  • 12.3. COVID-19 And Hematological Abnormalities
  • 12.4. Future Outlook

13. Global Hematology Drugs Market Size And Growth

  • 13.1. Market Size
  • 13.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 13.2.1. Drivers Of The Market 2015 - 2020
    • 13.2.2. Restraints On The Market 2015 - 2020
  • 13.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
    • 13.3.1. Drivers Of The Market 2020 - 2025
    • 13.3.2. Restraints On The Market 2020 - 2025

14. Hematology Drugs Market, Regional Analysis

  • 14.1. Global Hematology Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.2. Global Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Region
  • 14.3. Global Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Region

15. Global Hematology Drugs Market Segmentation

  • 15.1. Global Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.1.1. Hemophilia
    • 15.1.2. Anemia
    • 15.1.3. Others
    • 15.1.4. Blood Products
  • 15.2. Global Hematology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.3. Global Hematology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.4. Global Hematology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.4.1. Branded
    • 15.4.2. Generic
  • 15.5. Global Hematology Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.5.1. Prescription
    • 15.5.2. OTC

16. Global Hematology Drugs Market Metrics

  • 16.1. Hematology Drugs Market Size, Percentage Of GDP, Global
  • 16.2. Per Capita Average Hematology Drugs Market Expenditure, Global

17. Asia-Pacific Hematology Drugs Market

  • 17.1. Asia-Pacific Hematology Drugs Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Background Information
    • 17.1.4. Government Initiatives
    • 17.1.5. Regulations
    • 17.1.6. Regulatory Bodies
    • 17.1.7. Major Associations
    • 17.1.8. Taxes Levied
    • 17.1.9. Corporate Tax Structure
    • 17.1.10. Investments
    • 17.1.11. Major Companies
  • 17.2. Asia-Pacific Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.3. Asia-Pacific Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.4. Asia-Pacific Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.5. Asia-Pacific Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 17.6. Asia-Pacific Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 17.7. Asia-Pacific Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 17.8. Asia-Pacific Hematology Drugs Market: Country Analysis
  • 17.9. Australia Hematology Drugs Market
  • 17.10. Australia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.11. Australia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.12. Australia Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.13. China Hematology Drugs Market
  • 17.14. China Hematology Drugs Market Overview
    • 17.14.1. Country Information
    • 17.14.2. Market Information
    • 17.14.3. Background Information
    • 17.14.4. Government Initiatives
    • 17.14.5. Regulations
    • 17.14.6. Regulatory Bodies
    • 17.14.7. Major Associations
    • 17.14.8. Taxes Levied
    • 17.14.9. Corporate Tax Structure
    • 17.14.10. Investments
    • 17.14.11. Major Companies
  • 17.15. China Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.16. China Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.17. China Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.18. Hong Kong Hematology Drugs Market
  • 17.19. Hong Kong Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.20. Hong Kong Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.21. India Hematology Drugs Market
  • 17.22. India Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.23. India Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.24. India Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.25. Indonesia Hematology Drugs Market
  • 17.26. Indonesia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.27. Indonesia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.28. Indonesia Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.29. Japan Hematology Drugs Market
  • 17.30. Japan Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.31. Japan Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.32. Japan Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.33. Malaysia Hematology Drugs Market
  • 17.34. Malaysia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.35. Malaysia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.36. New Zealand Hematology Drugs Market
  • 17.37. New Zealand Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.38. New Zealand Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.39. Philippines Hematology Drugs Market
  • 17.40. Philippines Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.41. Philippines Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.42. Singapore Hematology Drugs Market
  • 17.43. Singapore Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.44. Singapore Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.45. South Korea Hematology Drugs Market
  • 17.46. South Korea Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.47. South Korea Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.48. South Korea Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.49. Thailand Hematology Drugs Market
  • 17.50. Thailand Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.51. Thailand Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.52. Vietnam Hematology Drugs Market
  • 17.53. Vietnam Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.54. Vietnam Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

18. Western Europe Hematology Drugs Market

  • 18.1. Western Europe Hematology Drugs Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulations
    • 18.1.6. Regulatory Bodies
    • 18.1.7. Major Associations
    • 18.1.8. Taxes Levied
    • 18.1.9. Corporate Tax Structure
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Western Europe Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.3. Western Europe Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.4. Western Europe Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.5. Western Europe Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 18.6. Western Europe Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 18.7. Western Europe Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 18.8. Western Europe Hematology Drugs Market: Country Analysis
  • 18.9. Austria Hematology Drugs Market
  • 18.10. Austria Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.11. Austria Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.12. Belgium Hematology Drugs Market
  • 18.13. Belgium Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.14. Belgium Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.15. Denmark Hematology Drugs Market
  • 18.16. Denmark Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.17. Denmark Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.18. Finland Hematology Drugs Market
  • 18.19. Finland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.20. Finland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.21. France Hematology Drugs Market
  • 18.22. France Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.23. France Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.24. France Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.25. Germany Hematology Drugs Market
  • 18.26. Germany Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.27. Germany Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.28. Germany Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.29. Ireland Hematology Drugs Market
  • 18.30. Ireland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.31. Ireland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.32. Italy Hematology Drugs Market
  • 18.33. Italy Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.34. Italy Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.35. Netherlands Hematology Drugs Market
  • 18.36. Netherlands Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.37. Netherlands Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.38. Norway Hematology Drugs Market
  • 18.39. Norway Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.40. Norway Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.41. Portugal Hematology Drugs Market
  • 18.42. Portugal Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.43. Portugal Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.44. Spain Hematology Drugs Market
  • 18.45. Spain Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.46. Spain Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.47. Sweden Hematology Drugs Market
  • 18.48. Sweden Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.49. Sweden Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.50. Switzerland Hematology Drugs Market
  • 18.51. Switzerland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.52. Switzerland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.53. UK Hematology Drugs Market
  • 18.54. UK Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.55. UK Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.56. UK Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Eastern Europe Hematology Drugs Market

  • 19.1. Eastern Europe Hematology Drugs Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Major Associations
    • 19.1.8. Taxes Levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Eastern Europe Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.3. Eastern Europe Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.4. Eastern Europe Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.5. Eastern Europe Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 19.6. Eastern Europe Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 19.7. Eastern Europe Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 19.8. Eastern Europe Hematology Drugs Market: Country Analysis
  • 19.9. Czech Republic Hematology Drugs Market
  • 19.10. Czech Republic Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.11. Czech Republic Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.12. Poland Hematology Drugs Market
  • 19.13. Poland Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.14. Poland Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.15. Romania Hematology Drugs Market
  • 19.16. Romania Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.17. Romania Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.18. Russia Hematology Drugs Market
  • 19.19. Russia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.20. Russia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.21. Russia Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. North America Hematology Drugs Market

  • 20.1. North America Hematology Drugs Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Background Information
    • 20.1.4. Government Initiatives
    • 20.1.5. Regulations
    • 20.1.6. Regulatory Bodies
    • 20.1.7. Associations
    • 20.1.8. Taxes Levied
    • 20.1.9. Corporate Tax Structure
    • 20.1.10. Investments
    • 20.1.11. Major players
  • 20.2. North America Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.3. North America Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.4. North America Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Billion)
  • 20.5. North America Hematology Drugs Market, 2020, By Country, Value ($ Billion)
  • 20.6. North America Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 20.7. North America Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 20.8. North America Hematology Drugs Market: Country Analysis
  • 20.9. Canada Hematology Drugs Market
  • 20.10. Canada Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.11. Canada Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.12. Mexico Hematology Drugs Market
  • 20.13. Mexico Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.14. Mexico Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.15. USA Hematology Drugs Market
  • 20.16. USA Hematology Drugs Market Overview
    • 20.16.1. Country Information
    • 20.16.2. Market Information
    • 20.16.3. Background Information
    • 20.16.4. Government Initiatives
    • 20.16.5. Regulations
    • 20.16.6. Regulatory Bodies
    • 20.16.7. Major Associations
    • 20.16.8. Taxes Levied
    • 20.16.9. Corporate Tax Structure
    • 20.16.10. Investments
    • 20.16.11. Major players
  • 20.17. USA Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Billion)
  • 20.18. USA Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Billion)
  • 20.19. USA Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Billion)

21. South America Hematology Drugs Market

  • 21.1. South America Hematology Drugs Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Regulations
    • 21.1.5. Regulatory Bodies
    • 21.1.6. Major Associations
    • 21.1.7. Taxes Levied
    • 21.1.8. Corporate Tax Structure
    • 21.1.9. Investments
    • 21.1.10. Major Companies
  • 21.2. South America Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.3. South America Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.4. South America Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.5. South America Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 21.6. South America Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 21.7. South America Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 21.8. South America Hematology Drugs Market: Country Analysis
  • 21.9. Argentina Hematology Drugs Market
  • 21.10. Argentina Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.11. Argentina Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.12. Brazil Hematology Drugs Market
  • 21.13. Brazil Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.14. Brazil Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.15. Brazil Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 21.16. Chile Hematology Drugs Market
  • 21.17. Chile Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.18. Chile Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.19. Colombia Hematology Drugs Market
  • 21.20. Colombia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.21. Colombia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.22. Peru Hematology Drugs Market
  • 21.23. Peru Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.24. Peru Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 21.25. Venezuela Hematology Drugs Market
  • 21.26. Venezuela Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 21.27. Venezuela Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

22. Middle East Hematology Drugs Market

  • 22.1. Middle East Hematology Drugs Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. Government Initiatives
    • 22.1.5. Regulations
    • 22.1.6. Regulatory Bodies
    • 22.1.7. Major Associations
    • 22.1.8. Taxes Levied
    • 22.1.9. Corporate Tax Structure
    • 22.1.10. Investments
    • 22.1.11. Major Companies
  • 22.2. Middle East Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.3. Middle East Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.4. Middle East Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 22.5. Middle East Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 22.6. Middle East Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 22.7. Middle East Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 22.8. Middle East Hematology Drugs Market: Country Analysis
  • 22.9. Israel Hematology Drugs Market
  • 22.10. Israel Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.11. Israel Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.12. Saudi Arabia Hematology Drugs Market
  • 22.13. Saudi Arabia Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.14. Saudi Arabia Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.15. Turkey Hematology Drugs Market
  • 22.16. Turkey Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.17. Turkey Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 22.18. UAE Hematology Drugs Market
  • 22.19. UAE Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 22.20. UAE Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

23. Africa Hematology Drugs Market

  • 23.1. Africa Hematology Drugs Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Background information
    • 23.1.4. Government Initiatives
    • 23.1.5. Regulations
    • 23.1.6. Regulatory Bodies
    • 23.1.7. Major Associations
    • 23.1.8. Taxes Levied
    • 23.1.9. Corporate Tax Structure
    • 23.1.10. Investments
    • 23.1.11. Major Companies
  • 23.2. Africa Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.3. Africa Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.4. Africa Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 23.5. Africa Hematology Drugs Market, 2020, By Country, Value ($ Million)
  • 23.6. Africa Hematology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
  • 23.7. Africa Hematology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
  • 23.8. Africa Hematology Drugs Market: Country Analysis
  • 23.9. Egypt Hematology Drugs Market
  • 23.10. Egypt Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.11. Egypt Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.12. Nigeria Hematology Drugs Market
  • 23.13. Nigeria Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.14. Nigeria Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 23.15. South Africa Hematology Drugs Market
  • 23.16. South Africa Hematology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 23.17. South Africa Hematology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

24. Hematology Drugs Global Market Competitive Landscape

  • 24.1. Company Profiles
  • 24.2. Takeda Pharmaceutical Company
    • 24.2.1. Company Overview
    • 24.2.2. Products And Services
    • 24.2.3. Business Strategy
    • 24.2.4. Financial Overview
  • 24.3. Roche Holding AG
    • 24.3.1. Company Overview
    • 24.3.2. Products And Services
    • 24.3.3. Business Strategy
    • 24.3.4. Financial Overview
  • 24.4. Amgen Inc.
    • 24.4.1. Company Overview
    • 24.4.2. Products And Services
    • 24.4.3. Business Strategy
    • 24.4.4. Financial Overview
  • 24.5. Novartis AG
    • 24.5.1. Company Overview
    • 24.5.2. Products And Services
    • 24.5.3. Business Strategy
    • 24.5.4. Financial Overview
  • 24.6. Novo Nordisk A/S
    • 24.6.1. Company Overview
    • 24.6.2. Products And Services
    • 24.6.3. Business Strategy
    • 24.6.4. Financial Overview

25. Key Mergers And Acquisitions In The Hematology Drugs Market

  • 25.1. Pfizer Acquired Trillium Therapeutics
  • 25.2. Morphosys Acquired Constellation Pharmaceuticals
  • 25.3. Jazz Pharmaceuticals Acquired GW Pharmaceuticals plc
  • 25.4. Bayer Acquired AskBio Biopharmaceutical
  • 25.5. AbbVie Acquired Allergan plc
  • 25.6. Sobi Acquired Dova Pharmaceuticals
  • 25.7. Hoffmann-La Roche Ltd. Acquired Spark Therapeutics
  • 25.8. AbbVie Acquired Pharmacyclics

26. Market Background: Pharmaceutical Drugs Market

  • 26.1. Pharmaceutical Drugs Market Characteristics
    • 26.1.1. Market Definition
    • 26.1.2. Segmentation By Type
  • 26.2. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 26.2.1. Metabolic Disorders Drugs
    • 26.2.2. Anti-Infective Drugs
    • 26.2.3. Central Nervous System Drugs
    • 26.2.4. Respiratory Diseases Drugs
    • 26.2.5. Cardiovascular Drugs
    • 26.2.6. Musculoskeletal Disorders Drugs
    • 26.2.7. Oncology Drugs
    • 26.2.8. Hematology Drugs
    • 26.2.9. Genito-Urinary Drugs
    • 26.2.10. Gastrointestinal Drugs
    • 26.2.11. Dermatology Drugs
    • 26.2.12. Ophthalmology Drugs
  • 26.3. Global Pharmaceutical Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

27. Hematology Drugs Market Future Outlook and Potential Analysis

  • 27.1. Global Hematology Drugs Market In 2025 - Countries Offering Most New Opportunities
  • 27.2. Global Hematology Drugs Market In 2025 - Segments Offering Most New Opportunities
  • 27.3. Global Hematology Drugs Market In 2025 - Growth Strategies
    • 27.3.1. Market Trend Based Strategies
    • 27.3.2. Competitor Strategies

28. Hematology Drugs Market, Conclusions And Recommendations

  • 28.1. Conclusions
  • 28.2. Recommendations
    • 28.2.1. Product
    • 28.2.2. Place
    • 28.2.3. Price
    • 28.2.4. Promotion
    • 28.2.5. People

29. Appendix

  • 29.1. Market Data Sources
  • 29.2. NAICS Definitions Of Industry Covered In This Report
  • 29.3. Research Methodology
  • 29.4. Currencies
  • 29.5. Research Inquiries
  • 29.6. The Business Research Company
  • 29.7. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!